S antigen

(redirected from Arrestin)
Also found in: Wikipedia.

S an·ti·gen

1. Synonym(s): soluble antigen
2. a photoreceptor protein found in rods and in the pineal gland, exerting an inhibitory function in the light transduction cascade. Synonym(s): arrestin
References in periodicals archive ?
Two key markers of the beta arrestin pathway - ERK1 and MUC5AC - which are necessary for the activation of mucous metaplasia in the airway, showed the most robust changes.
D2R acts by ligand-dependent signalling through two major systems: the G-proteins, and the Arrestin proteins (Arr-s).
These included cyclic nucleotide gated ion channels (CNG) required to transfer the signal and a hydra version of arrestin, which wipes the phototransduction slate clean for a second signal.
Literaturdeki bir seride cerrahi etkin bir yontem olarak ongorulmekte ancak cerrahi uncesi bizim hastamizda oldugu gibi kardiyak arrestin cerrahi sonrasi icin kotu prognoz oldugu vurgulanmaktadir (7).
A special section is included in this year's edition on [Beta]-arrestins with topics that include the role of [Beta]-arrestin-mediated signaling in chemotaxis cellular process, their role in regulating signaling by receptor tyrosine kinases (RTKs), and the role of G protein- coupled receptor kinases and arrestins.
Parricelli also makes a distinctive solo mark, often providing the most arrestin g interludes, benefiting from their contrastingly electric edge.
The study, Crystal structure of rhodopsin bound to arrestin determined by femtosecond X-ray laser, was published today in the journal Nature.
This ground-breaking technology will be validated with well-chosen case studies covering key PPIs of the GPCR transmembrane signaling pathway including parts of the arrestin interactome.
For cellular immunodetection of [beta]-arrestin, we used a mouse monoclonal antibody that recognizes both arrestin isoforms (BD Bioscience, San Diego CA), and for [beta]-arrestin Western blot detection, an antibody generously provided by R.
ERK2, a biomarker for the beta arrestin pathway, showed a greater median decrease than placebo-treated patients resulting in a lower median value at visit 7 (487 v 1,910 pg/mL);
The combined offering bundles Caliper LabChip systems with DiscoveRx's cellular assays, including PathHunter(TM) Beta Arrestin and cAMP Hunter(TM), to assist pharmaceutical and biotechnology researchers in more efficiently discovering GPCR drugs.